The Academy of Medical Sciences is pleased to announce the appointment of Rosalind Campion as its new Chief Executive Officer

Rosalind brings extensive leadership experience across the health and life sciences sector. She has led the Government’s Office for Life Sciences for the last four years, bringing together the Government, the NHS, academia and industry to drive improved patient outcomes and economic growth through life sciences. She led the development of the recently published Life Sciences Sector Plan, which sets out a bold ambition for the UK to become the third most important life sciences economy in the world by 2035. In her role at OLS she has worked with the Academy of Medical Sciences’ Fellows and partners across the health system; she has been at the heart of driving forward the UK’s most critical initiatives to improve biomedical and health research.  

Rosalind began her career as a solicitor working in the City before moving into Government, where she held senior leadership roles on social and economic policy issues, from setting up and running the Sentencing Council, to key roles in the Cabinet Office, the Home Office and in the Department of International Trade. She spent more than six years working as a senior diplomat working on economic issues in Washington DC and Tokyo, including leading the UK’s science and tech teams in both countries.  

Rosalind Campion will take on the role of Chief Executive Officer from 20 October 2025, succeeding Jill Lockett who has been covering the role on an interim basis since May 2025.  

Welcoming the appointment, Professor Andrew Morris CBE FRSE PMedSci, President of the Academy of Medical Sciences, said:  

Roz brings a wealth of expertise to the Academy, and we very much look forward to welcoming her as our Chief Executive. She has extensive experience operating at the highest level, including working with many of our Fellows. Her strategic insight across Government and the Life Sciences sector, coupled with her commitment to fostering impactful collaborations both in the UK and internationally, positions her exceptionally well. I am excited by the opportunity to work with Roz and our Fellowship to guide the Academy at this crucial juncture for biomedical and health research.

Rosalind Campion commented:  

I am very proud to have been appointed to be the CEO of the Academy of Medical Sciences. Progress in medical sciences is transforming the lives of patients in the UK and globally, and can fundamentally improve the UK's economy and productivity. I am looking forward to working closely with Fellows, staff and partners to advance the Academy's mission.

 UK Science Minister Lord Vallance FRS FMedSci HonFREng, said: 

The Academy of Medical Sciences plays a crucial role in medicine and science in the UK. In appointing Roz Campion, the Academy are getting a leader who has been at the heart of the UK’s life sciences sector as Director of the Government’s Office for Life Sciences. She brings insight and experience, a natural grasp for entrepreneurship and strong relationships across the sector. I look forward to continuing to work with her and the Academy, as we work to bring the ambitious aims of the Life Sciences Sector Plan to fruition.

 John-Arne Røttingen, Chief Executive Officer of the Wellcome Trust, said:  

Having worked with Roz in her time at the Office for Life Sciences, I know her vision and energy will take the Academy from strength to strength in their mission to ensure research supports better health for people everywhere. At Wellcome, we look forward to continuing our important partnership with the Academy under Roz’s leadership and offer our congratulations on her appointment.